1. 2022-RA-1174-ESGO Role of adjuvant therapy in intermediate-risk cervical cancer patients – SCCAN study sub-analysis. (20th October 2022) Authors: Cibula, David; Akilli, Huseyin; van Lonkhuijzen, Luc RCW; Fagotti, Anna; Dostálek, Lukáš; Ortiz, David Isla; Meydanli, Mehmet Mutlu; Abu-Rustum, Nadeem R; Odetto, Diego; Landoni, Fabio; Presl, Jiri; Klat, Jaroslav; Falconer, Henrik; Lopez, Aldo; Reis, Ricardo dos; Zapardiel, Ignacio; Laky, Rene; ... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-RA-1257-ESGO MILACC Study: Is the manipulation with LN containing undetected micrometastases the underlying cause of higher rate of local recurrences in the LACC trial?. (20th October 2022) Authors: Cibula, David; Nitecki, Roni; Dundr, Pavel; Nemejcova, Kristyna; Ribeiro, Reitan; Vieira Gomes, Mariano Tamura; Schmidt, Ronaldo Luis; Bedoya, Lucio; Ortiz, David Isla; Pareja, Rene; Rendón Pereira, Gabriel Jaime; Blanco, Aldo López; Kushner, David M; Ramirez, Pedro T Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2022-RA-1301-ESGO The impact of hospital surgical volume on survival in early-stage cervical cancer treated with radical hysterectomy: a sub-analysis of the SCCAN study. (20th October 2022) Authors: Bizzarri, Nicolò; Dostálek, Lukáš; Lonkhuijzen, Luc RCW; Giannarelli, Diana; Lopez, Aldo; Falconer, Henrik; Querleu, Denis; Ayhan, Ali; Kim, Sarah H; Ortiz, David Isla; Klat, Jaroslav; Obermair, Andreas; Landoni, Fabio; Rodriguez, Juliana; Manchanda, Ranjit; Kosťun, Jan; Ramirez, Pedro T; Meydanl... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2022-RA-1392-ESGO Tisotumab vedotin combinations with pembrolizumab or carboplatin in patients with recurrent/metastatic cervical cancer: interim results of ENGOT Cx8/GOG-3024/innovaTV205. (20th October 2022) Authors: Lorusso, Domenica; Vergote, Ignace; O'Cearbhaill, Roisin E; Westermann, Anne M; Banerjee, Susana; van Nieuwenhuysen, Els; Iglesias, David A; Collins, Dearbhaile; Cibula, David; Madsen, Kristine; Tewari, Krishnansu S; Pignata, Sandro; Baurain, Jean-Francois; Boere, Ingrid A; Denys, Hannelore; Andr... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 2022-RA-1548-ESGO Trial in progress update on ENGOT-cx8/GOG-3024/innovaTV 205: addition of a new cohort using first-line tisotumab vedotin + pembrolizumab + carboplatin ± bevacizumab in recurrent/metastatic cervical cancer. (20th October 2022) Authors: Vergote, Ignace; Mirza, Mansoor; Sehouli, Jalid; Lorusso, Domenico; Kose, Fatih; Cibula, David; Westermann, Anneke; Collins, Dearbhaile; Banerjee, Susana; Oaknin, Ana; Soumaoro, Ibrahima; Jain, Shweta; Monk, Bradley J Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 2022-RA-1579-ESGO RACE: retrospective study on rare types of cervical cancer- CEEGOG CX-06. (20th October 2022) Authors: Dovnik, Andraž; Pakiž, Maja; Frühauf, Filip; Cibula, David Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 2022-RA-1638-ESGO Randomized phase III trial on Niraparib-TSR-042 (dostarlimab) versus physician's choice in recurrent ovarian, fallopian tube, or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33). (20th October 2022) Authors: Salutari, Vanda; Musacchio, Lucia; Pignata, Sandro; Braicu, Elena; Cibula, David; Colombo, Nicoletta; Frenel, Jean Sebastien; Giolitto, Serena; Camarda, Floriana; Perri, Maria Teresa; Giudice, Elena; Scambia, Giovanni; Lorusso, Domenica Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A356 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 2022-RA-222-ESGO Quality of life after extended pelvic exenterations. (20th October 2022) Authors: Lednický, Štefan; Hoschlová, Eva; Sláma, Jiří; Wiesnerová, Markéta; Mitáš, Petr; Matějovský, Zdeněk; Schneiderová, Michaela; Dundr, Pavel; Němejcová, Kristýna; Burgetová, Andrea; Zámečník, Libor; Vočka, Michal; Kocián, Roman; Fruehauf, Filip; Dostálek, Lukáš; Fischerová, Daniela; Borčinová, Marti... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A390 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 2022-RA-426-ESGO Stratification of lymph node metastases as macrometastases, micrometastases, or isolated tumor cells has no clinical impact in patients with cervical cancer: subgroup analysis of the SCCAN project. (20th October 2022) Authors: Dostálek, Lukáš; Benešová, Klára; Klát, Jaroslav; Kim, Sarah H; Falconer, Henrik; Kostun, Jan; Ricardo, dos Reis; Zapardiel, Ignacio; Ortiz, David Isla; van Lonkhuijzen, Luc RCW; Lopez, Aldo; Odetto, Diego; Borčinová, Martina; Jarkovský, Jiří; Salehi, Sahar; Nemejcová, Kristýna; Dundr, Pavel; Par... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 2022-RA-459-ESGO UPLIFT (ENGOT-ov67/GOG-3048) a registrational trial of Upifitamab Rilsodotin (XMT-1536; UpRi), a NaPi2b-directed antibody drug conjugate (ADC) in platinum-resistant ovarian cancer. (20th October 2022) Authors: Concin, Nicole; Monk, Bradley J; Mirza, Mansoor Raza; Coleman, Robert L; Ray-Coquard, Isabelle; Pothuri, Bhavana; Baurain, Jean-Francois; Alejandro Perez-Fidalgo, J; Cibula, David; Saverse, Antonella; Banerjee, Susana; Madry, Radek; Marth, Christian; Putiri, Emily; Barrett, Jamie; DeMars, Leslie;... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗